Recall: Tirosint

Feb. 2023Pharmacy Updates
IBSA Pharma Inc. has recalled 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution because these lots may be subpotent (they have a lower than normal or acceptable potency). Read the full text of the Tirosint recall.

Recent Announcements

Special notice: Important policy changes

Effective June 1, 2025, UPMC Health Plan will be implementing policy changes that will require providers to obtain prior authorizations for services listed in the following policies. For more information, please visit upmchp.us/policiesandprocedures.
May 2025Important Notices

Provider OnLine Enhancements

Provider OnLine will be launching enhancements to the authorization process on April 18, 2025. The enhancement will include the following updates:
Apr. 2025Important Notices

Fostering Trust in Vaccinations Through Shared Decision Making

Please join us for a live, CME-accredited webinar on Wednesday, June 4, from noon to 1 p.m. that will provide an overview of fostering trust in vaccinations through shared decision making.
Apr. 2025Education/Webinars